Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2018
SIETES contiene 92559 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
3.Tiene citas relacionadas Cita con resumen
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S D, Schmidikofer S, Westwood M, Kleijnen J. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313:2456-73. [Ref.ID 99308]
4. Cita con resumen
Kuehn BM. Off-label atypical antipsychotics. JAMA 2012;308:1198. [Ref.ID 93799]
5.Enlace a cita original Cita con resumen
Stafford N. German patients are allowed marijuana for medical uses. BMJ 2009;338:500. [Ref.ID 85385]
6.
Heyman I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ 2006;333:424-9. [Ref.ID 77887]
7.
Chowdhury U. Tourette's syndrome in children. BMJ 2004;329:1356-7. [Ref.ID 72138]
8. Cita con resumen
Anónimo. The Netherlands first to sell cannabis on prescription. Scrip 2003;2882:4. [Ref.ID 67308]
9. Cita con resumen
Leckman JF. Tourette's syndrome. Lancet 2002;360:1577-86. [Ref.ID 64084]
10. Cita con resumen
Stein DJ. Obsessive-compulsive disorder. Lancet 2002;360:397-405. [Ref.ID 63179]
11.
Kossoff EH, Singer HS. Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 2001;3:355-63. [Ref.ID 56717]
12.
Williamson EM, Evans FJ. Cannabinoids in clinical practice. Drugs 2000;60:1303-14. [Ref.ID 54218]
13. Cita con resumen
Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000;21:218-24. [Ref.ID 51347]
14.Tiene citas relacionadas
Perlmutter S J, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354:1153-8. [Ref.ID 47115]
15.Tiene citas relacionadas Cita con resumen
Singer HS. PANDAS and immunomodulatory therapy. Lancet 1999;354:1137-8. [Ref.ID 47112]
16.
Santosh PJ, Baird G. Psychopharmacotherapy in children and adults with intellectual disability. Lancet 1999;354:231-40. [Ref.ID 46003]
17.
Zametkin AJ, Ernst M. Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med 1999;340:40-6. [Ref.ID 42377]
18.
Sanberg PR, Shytle RD, Silver AA. Treatment of Tourette's syndrome with mecamylamine. Lancet 1998;352:705-6. [Ref.ID 40177]
19. Cita con resumen
Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA. Drug-induced movement disorders. Drug Saf 1997;16:180-204. [Ref.ID 31374]
20.
Thomas RJ, Reagan D R. Association of a tourette-like syndrome with ofloxacin. Ann Pharmacother 1996;30:138-41. [Ref.ID 26245]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>